Researchers study long-term safety of lentiviral gene therapy in primates, finding no evidence of somatic mutations or ...

Hyperextension is a joint and muscle injury. It also refers to a form of exercise involving a bench. Find examples and ...

An international research team has developed a new therapy based on nanotechnology called nanoGLA for the treatment of Fabry ...

The 2022 Inflation Reduction Act (IRA) has introduced significant challenges for the pharmaceutical industry, altering the ...

AIIMS Delhi has achieved a groundbreaking milestone in cancer treatment by developing an antibody-based therapy for recurrent cancers, specifically M ...

Researchers at the University of Plymouth are leading an innovative initiative to advance the study of meningiomas in NF2-related schwannomatosis (NF2-SWN).

AbbVie announced positive topline results from its pivotal Phase III TEMPO-2 trial, evaluating tavapadon as a flexible-dose (5mg to 15mg, once daily) monotherapy in early Parkinson's disease (PD).

Alongside the FDA’s orphan drug designation in the U.S., the European Commission’s orphan medicinal product designation for mitapivat underscores the urgent need for novel therapies for sickle cell ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...

Vitamin D regulates hormones, reduces menstrual pain, supports fetal development and preserves bone health during menopause.

In an official announcement the Russian Health Ministry said that a cancer vaccine will be launched in 2025 and will be administered to patients for free.

Pfizer Inc. (NYSE:PFE) today provided its full-year 2025 guidance(1) and reaffirmed its October 29, 2024 full-year 2024 guidance(1) . The accompanying ...